HOA with Arrotex(Australias Largest Generic OTC Supplier), to accelerate NanoCB access for Pharmacy; Dr Sean Hall, CEO of Medlab states, “This is a major milestone for both the Australian market and the budding partnership between Medlab and Arrotex. Unlike many CBD producers, Medlab can deliver to the pharmaceutical standards required for TGA approval and this partnership will now enable direct application into clinical practice through Arrotex’s extensive network. There is a clear alignment within both companies to deliver a superior, approved CBD product to Australian patients.”
- Development positions NanoCBD™ for pharmacist only medicines schedule (S3)
- Medlab’s pharmaceutical standards of safety, stability and dose specifics primed for fast application to TGA registration
- NanoCBD™ significantly differentiated by Medlab’s proprietary delivery platform, NanoCelle®
http://wcsecure.weblink.com.au/pdf/MDC/02342965.pdf
- Forums
- ASX - By Stock
- MDC
- How big could MDC be? Answer: Stupid big
How big could MDC be? Answer: Stupid big, page-21
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MDC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.60 |
Change
0.000(0.00%) |
Mkt cap ! $15.07M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MDC (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online